Universal BRCA testing worthwhile for relatives of high-grade serous ovarian cancer patients
April 28, 2018|ObGyn
REPORTING FROM ACOG 2018
“Any opportunity to prevent ovarian cancer is worthwhile,” Dr. Kwon commented. “If an ovarian cancer patient cannot be tested because she declines testing or, more commonly, because she is deceased, her first-degree relative should have BRCA mutation testing, regardless of other personal or family history or ethnicity.”
She and her coinvestigators reported no relevant financial disclosures.
